N/A(healthy adults)
Conditions
Interventions
Sponsors
MORINAGA & CO., LTD.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1)Japanese individuals aged 20-39 years. 2)Individuals who are healthy and are not suffered from a chronic malady. 3)Individuals whose written informed consent has been obtained. 4)Individulals who can visit an inspection facility and be inspected in designated days. 5)Individuals judged appropriate for the study by the principal. 6)Individuals who can draw blood from a fingertip.
Exclusion criteria
Exclusion criteria: 1)Individuals using medical products. 2)Individuals with dementia or sleep disorder. 3)Individuals who have a history of serious hepatopathy, kidney damage, heart disease, lung and blood disease. 4)Individuals who contract or have a history of serious gastrointestinal disease. 5)Individuals who have an addiction to alcohol or a mental illness. 6)Individuals who used a drug for treatment of disease in the past 1 month. 7)Individuals with probable seasonal allergy, such as pollinosis, during the test period.(Betulaceae: alder, oba alnus firma, shirakaba, Taxodiaceae: cryptomeria, hinoki cypress, Asteraceae: ragweed, Artemisia vulgaris indica, Gramineae: Dactylis glomerata, Phleum pratense) 8)Individuals who contract or have a history of food allergy. 9)Individuals with serious anemia. 10)Individuals with high blood glucose (fasting blood glucose over 126 mg/dL). 11)Individuals who are a smoker. 12)Females who are or are possibly pregnant, or are lactating. 13)Individuals whose life style will change during the test period. 14)Individuals who had a habit to ingest health-promoting foods, foods for specified health uses, health foods, or supplements in the past 3 months or will ingest those foods during the test period. 15)Individuals who had a habit to ingest foods claiming to improve cognitive function, foods for specified health uses, health foods, or supplements in the past 3 months or will ingest those foods during the test period. 16)Individuals who had a habit to use drug claiming to improve cognitive function in the past 3 months. 17)Individuals who were hospitalized and received treatment in the past 6 months, or will be hospitalized during the test period. 18)Individuals who participated in other clinical studies in the past 1 months. 19)Individuals judged inappropriate for the study by the principal.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Japanese version of the CNS Vital Signs (Cognitrax) | — |
Secondary
| Measure | Time frame |
|---|---|
| Doctor's questions, blood glucose | — |
Countries
Japan
Contacts
Public ContactSadao Mori
Morinaga & Co.,Ltd Health Science and Research Center, R&D institute
Outcome results
None listed